Lummer, Carina
Eggers, Carsten
Becker, Andreas
Demandt, Fenja
Warnecke, Tobias https://orcid.org/0000-0001-8979-5900
,
Article History
Received: 3 October 2023
Accepted: 5 December 2023
First Online: 11 January 2024
Declarations
:
: As no patients were surveyed, approvement by an ethics committee was not necessary. All surveyed parties gave their informed consent to participate.
: All authors gave their consent for publication of the final manuscript.
: CL declares a conflict of interest. CL is scientifically working for OptiMedis AG, who is supporting the non-profit association "Parkinson Netzwerke Deutschland e.V." in advancing its work in Germany. However, this COI did not in any way interfere with the analysis and interpretation of the research. All co-authors have assessed and approved analysis and interpretation of the results. CE has received honoraria and attended advisory boards from AbbVie, Stadapharm, Bial and Bristol-Myers Squibb. AB has received honoraria and funding from AbbVie. FD reports no conflict of interest. TW has received honoraria from BIAL, Abbvie, Desitin, Pfitzer, Britannia, Esteve and Licher, consultancies from Stadapharm and Phagenesis, and funding from Abbvie.